Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-07

Clinical Trial Update: A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a suprachoroidal stent in open-angle glaucoma patients treated with two topical hypotensive medications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • suprachoroidal stent

Snippet

Sponsor: Glaukos Corporation | Conditions: Subject With Primary Open-angle Glaucoma (POAG) | Phase 4 | Status: COMPLETED